Patricia D'Amore, PhD, MBA, the Charles L. Schepens Professor of Ophthalmology at Harvard Medical School and Vice Chair of Basic and Translational Research at Harvard Ophthalmology, has been...
Patricia A. D'Amore, PhD, MBA, Vice Chair of Basic and Translational Research at Harvard Ophthalmology, was recognized by Regis College with the Shining...
Patricia A. D’Amore, PhD, MBA, the Charles L. Schepens Professor of Ophthalmology at Harvard Medical School (HMS), Vice Chair for Basic and Translational Research at HMS, and Co-Director of the...
On November 2, the 20th Annual Boston Angiogenesis Meeting (BAM) event attracted more than 100 faculty members and trainees from several Boston-area institutions to present, discuss, and network...
Boston, Mass. — Patricia A. D’Amore, Ph.D., MBA, the Charles L. Schepens Professor of Ophthalmology at Harvard Medical School, Vice Chair for Basic and Translational Research, and Director of the...
As part of the National Eye Institute Audacious Goals Initiative, the National Institutes of Health awarded $12.4 million to six research teams to identify biological factors that affect neural...
Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health...
Patricia D'Amore, PhD, MBA, was the inaugural honoree of the Distinguished Alumna Award at Matignon High School's (Cambridge, MA) second annual Tradition of Excellence Gala. This award recognizes...
Patricia A. D’Amore, PhD, MBA, FARVO, the Charles L. Schepens Professor of Ophthalmology and Professor of Pathology at Harvard Medical School (HMS), was selected for the prestigious HMS William Silen...
Mass. Eye and Ear researchers describe the role of endomucin, a molecule that – under healthy circumstances – resists the adhesion of white blood cells as they move through the circulatory system...
Petr Baranov, MD, received the Alice Adler Award of $30,000 over one year from Harvard Medical School for his project, "High-throughput screening assay to identify photoreceptor pre-survival molecules...
World-renowned scientific award, often called the "Nobel Prize of Vision," recognizes the groundbreaking development of anti-angiogenic therapy for retinal disease
BOSTON (May 20, 2014) –Two prominent faculty members of the Harvard Medical School Department of Ophthalmology and Massachusetts Eye and Ear/Schepens Eye Research Institute were selected by the...